Glow-in-the-Dark dye could help surgeons spot hidden cancer in kids
NCT ID NCT07399821
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a special dye called anti-GD2-800CW that makes neuroblastoma cells glow during surgery. About 22 children with neuroblastoma will receive a single dose of the dye before their operation. The goal is to find the safest and most effective dose to help surgeons see and remove all tumor tissue.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
anti-GD2-800CW (a fluorescent dye that attaches to neuroblastoma cells)
What this could lead to
If successful, this could help surgeons remove neuroblastoma tumors more completely during surgery by making cancer cells glow.
What could go wrong
This is an early-phase study with only 22 children, so the dye may not work as hoped or could cause side effects. It is not a treatment for the cancer itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Prinses Maxima Centrum
RECRUITINGUtrecht, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••